메뉴 건너뛰기




Volumn 53, Issue 12, 2013, Pages 3203-3209

Quality of freeze-dried (lyophilized) quarantined single-donor plasma

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ANTIPLASMIN; ANTITHROMBIN; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 8; FIBRINOGEN; FREEZE DRIED PLASMA; FRESH FROZEN PLASMA; LYOPLAS; PLASMA SUBSTITUTE; PLASMINOGEN; PROTEIN S; RISTOCETIN; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

EID: 84890431339     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12191     Document Type: Article
Times cited : (72)

References (26)
  • 1
    • 77956310036 scopus 로고    scopus 로고
    • American Association of Blood Banks, American Red Cross, America's Blood Centers, and Armed Services Blood Program Bethesda (MD): American Association of Blood Banks
    • American Association of Blood Banks, American Red Cross, America's Blood Centers, and Armed Services Blood Program. Circular of information for the use of human blood and blood components. Bethesda (MD): American Association of Blood Banks; 2009.
    • (2009) Circular of Information for the Use of Human Blood and Blood Components
  • 2
    • 84855215536 scopus 로고    scopus 로고
    • BÄK: Cross-sectional guidelines for therapy with blood components and plasma derivatives
    • Bundesärztekammer (BÄK).: and 2011;38:71.
    • Bundesärztekammer (BÄK). BÄK: cross-sectional guidelines for therapy with blood components and plasma derivatives. Transfus Med Hemother 2009; 36: 345-492 and 2011;38:71.
    • (2009) Transfus Med Hemother , vol.36 , pp. 345-492
  • 6
    • 80052527989 scopus 로고    scopus 로고
    • Blood product use in trauma resuscitation: Plasma deficit versus plasma ratio as predictors of mortality in trauma
    • De Biasi A, Stansbury LG, Dutton RP, Stein DM, Scalea TM, Hess JR,. Blood product use in trauma resuscitation: plasma deficit versus plasma ratio as predictors of mortality in trauma. Transfusion 2011; 51: 1925-1932.
    • (2011) Transfusion , vol.51 , pp. 1925-1932
    • De Biasi, A.1    Stansbury, L.G.2    Dutton, R.P.3    Stein, D.M.4    Scalea, T.M.5    Hess, J.R.6
  • 11
    • 84890434792 scopus 로고    scopus 로고
    • Freeze-dried plasma. the trail back to the battlefield
    • Barrows E,. Freeze-dried plasma. The trail back to the battlefield. Def AT&L 2006; Sept-Oct: 16-19.
    • (2006) Def AT&L , pp. 16-19
    • Barrows, E.1
  • 13
    • 4043144681 scopus 로고    scopus 로고
    • Quality and Safety Directive 2002/98/EC
    • European Parliament and Council of the European Union. 8.2.
    • European Parliament and Council of the European Union. Quality and Safety Directive 2002/98/EC. Off J Eur Union 8.2. 2003; L33: 30-40.
    • (2003) Off J Eur Union , vol.33 L , pp. 30-40
  • 15
  • 17
    • 55349089928 scopus 로고    scopus 로고
    • Proteomic characterization of freeze-dried human plasma: Providing treatment of bleeding disorders without the need for a cold chain
    • Steil L, Thiele T, Hammer E, Bux J, Kalus M, Völker U, Greinacher A,. Proteomic characterization of freeze-dried human plasma: providing treatment of bleeding disorders without the need for a cold chain. Transfusion 2008; 48: 2356-2363.
    • (2008) Transfusion , vol.48 , pp. 2356-2363
    • Steil, L.1    Thiele, T.2    Hammer, E.3    Bux, J.4    Kalus, M.5    Völker, U.6    Greinacher, A.7
  • 18
    • 67650606350 scopus 로고
    • Lyophilized normal human plasma control in the pro-thrombin time clotting test. A
    • Oktavec WA, Smetana EJ,. Lyophilized normal human plasma control in the pro-thrombin time clotting test. A. J Clin Pathol 1954; 24: 250.
    • (1954) J Clin Pathol , vol.24 , pp. 250
    • Oktavec, W.A.1    Smetana, E.J.2
  • 19
    • 33845186830 scopus 로고    scopus 로고
    • A third episode of transfusion-derived vCJD
    • Wilson K, Ricketts MN,. A third episode of transfusion-derived vCJD. Lancet 2006; 368: 2037-2039.
    • (2006) Lancet , vol.368 , pp. 2037-2039
    • Wilson, K.1    Ricketts, M.N.2
  • 20
    • 69249194658 scopus 로고    scopus 로고
    • Virus inactivation during freeze-drying processes as used for the manufacture of plasma-derived medicinal products
    • Unger U, Poelsler G, Modrof J, Kreil L,. Virus inactivation during freeze-drying processes as used for the manufacture of plasma-derived medicinal products. Transfusion 2009; 49: 1924-1930.
    • (2009) Transfusion , vol.49 , pp. 1924-1930
    • Unger, U.1    Poelsler, G.2    Modrof, J.3    Kreil, L.4
  • 21
    • 78651284022 scopus 로고    scopus 로고
    • A comparison of methods of pathogen inactivation of FFP
    • Rock G,. A comparison of methods of pathogen inactivation of FFP. Vox Sang 2011; 100: 169-178.
    • (2011) Vox Sang , vol.100 , pp. 169-178
    • Rock, G.1
  • 22
    • 77955729111 scopus 로고    scopus 로고
    • Lyophilised plamsa: Evaluation of clotting factor activity over 6 days after reconstitution for transfusion
    • Schoenfeld H, Pruss A, Keller M, Schuster M, Meinck K, Neuner B, von Heymann C,. Lyophilised plamsa: evaluation of clotting factor activity over 6 days after reconstitution for transfusion. J Clin Pathol 2010; 63: 726-730.
    • (2010) J Clin Pathol , vol.63 , pp. 726-730
    • Schoenfeld, H.1    Pruss, A.2    Keller, M.3    Schuster, M.4    Meinck, K.5    Neuner, B.6    Von Heymann, C.7
  • 25
    • 0036073239 scopus 로고    scopus 로고
    • Comparative safety and efficacy of Bioplasma FDP versus single-donor fresh-dried plasma in cardiopulmonary bypass patients
    • Chapanduka ZC, Fernandes-Costa FJ, Rochat C, Blyth DF,. Comparative safety and efficacy of Bioplasma FDP versus single-donor fresh-dried plasma in cardiopulmonary bypass patients. S Afr Med J 2002; 92: 356-357.
    • (2002) S Afr Med J , vol.92 , pp. 356-357
    • Chapanduka, Z.C.1    Fernandes-Costa, F.J.2    Rochat, C.3    Blyth, D.F.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.